[Federal Register Volume 63, Number 47 (Wednesday, March 11, 1998)]
[Notices]
[Pages 11897-11900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-6193]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[INFO-98-13]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Seleda Perryman, 
Assistant CDC Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Projects

    1. TB in Children (0920-0400)--Extension--National Center for HIV, 
STP, and TB Prevention--As a result of the rise of tuberculosis among 
children, CDC sponsored a Workshop on TB in Children a few years ago. 
Recommendations from the workshop included the need for further 
research concerning the epidemiology of TB in children, including 
children co-infected with HIV, improved diagnostic technologies, and 
the infectiousness of TB in children in health care settings. A 
contract with Columbia University (to study children in New York City) 
and with the University of California, San Diego (to study children in 
San Diego) was approved in December, 1996. The contract consisted of 
three Modules. Module II, Studies of the Diagnosis of TB in Children, 
was canceled in December, 1997 due to a lack of participant response. 
Module III, Reducing the Risk of Nosocomial Transmission of 
Tuberculosis in Pediatric Settings, has completed data collection and 
the results are being analyzed. Data collection for Module I, 
Epidemiology, Magnitude and Risk Factors for TB in children, including 
HIV-infected Children, was not completed within the original OMB 
timeframe. This is mainly due to the recent decline in TB incidence in 
children experienced in the last year in the two study areas.
    Data collection will need to be completed for Module I. The data 
collected to date is not useful because the numbers are too small to be 
statistically significant to meet the study objectives.
    Estimated cost to respondents and government: The costs of 
epidemiologists working on the contract will be $100,000. This is 
included in the total cost of the contract which is $1.8 million.
    Clinicians will interview parents of pediatric TB cases and 
controls. We have estimated a payment of $10 per hour of parents time 
for the interviews. The costs are estimated as follows:
    (a) Positive TST's--$10 @ hr. divided by 3 multiplied by 100=s 
$333.33
    (b) Negative TST's--$10 @ hr. divided by 3 multiplied by 200=s 
$666.67
    (c) Source case--$10 @ hr. divided by 2 multiplied by 150=s $750.00
    Total cost is: $1750.00.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden/               
                   Respondents                       Number of      responses/     response (in    Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Positive Tuberculin Skin Tests (TST's)..........             100               1           0.333              33
Negative TST's..................................             200               1           0.333              68
Source Case.....................................             150               1           0.5                75
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............             176
----------------------------------------------------------------------------------------------------------------


[[Page 11898]]

    2. Evaluation of the C. Everett Koop Community Health Information 
Center (CHIC)--New--The National Center for Chronic Disease Prevention 
and Health Promotion intends to conduct a survey of 25 individuals who 
pay for library research services from the CHIC and an additional 50 
individuals who represent members of key intermediary organizations 
that the CHIC would like to reach but is currently not reaching. The 
specific topic area for this study relates to the ability of the CHIC 
to meet the health information needs of the general public.
    The purpose of this survey is to determine:

--The level of satisfaction with CHIC services among paying patrons who 
request services via telephone (the CHIC currently conducts a 
satisfaction survey with all walk-in patrons)
--The level of knowledge about the CHIC among key intermediary 
individuals and organizations
--The health information needs of key intermediary individuals and 
organizations
--How to market CHIC services to key intermediary individuals and 
organizations

    Results from this research will be used to help evaluate the 
effectiveness of the CHIC in meeting the health information needs of 
the general public. Results from this research will provide the 
government with information about the efficacy of health information 
centers. In addition, this information will also be used by the CHIC to 
further enhance their ability to deliver health information services to 
the public residing in the Delaware Valley. There is no cost to the 
respondents.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
               Type of respondents                   Number of      responses/     response  (in   Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Paying Patrons..................................              25               1             .17             4.0
Key Intermediaries..............................              50               1             .25            12.5
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............            16.5
----------------------------------------------------------------------------------------------------------------

    3. National CDC AIDS and STD Hotline Callers Survey--Extension--
(0920-0295)--The National Center for HIV, STD, and TB Prevention 
(NCHSTP) is requesting clearance to gather information for management 
and evaluation purposes. The information gathered will assists NCHSTP 
in the improvement of HIV/STD services to high risk populations. Every 
30th caller to the National AIDS Hotline and every 15th caller to the 
National STD Hotline will be surveyed. Only callers to the AIDS and STD 
Hotlines will be affected. Respondents (callers) will be the general 
public. There is no cost to the respondent.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
                   Respondents                       Number of      responses/     response  (in   Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Callers to the Hotline..........................          28,311               1           .0236             595
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............             595
----------------------------------------------------------------------------------------------------------------

    4. Audience-Derived Input Regarding Campaign Development To Promote 
Colorectal Cancer Screening--New--The National Center for Chronic 
Disease Prevention and Health Promotion, Division of Cancer Prevention 
and Control is requesting clearance to gather information about 
colorectal cancer screening. Colorectal cancer is the second leading 
cause of cancer-related deaths in the United States. In 1997, 
approximately 131, 200 new cases of colorectal cancer will have been 
diagnosed, and an estimated 54,900 deaths will be caused by the 
disease. When colorectal cancer is detected early, chances for survival 
are greatly enhanced: current studies indicate that deaths from 
colorectal cancer could be reduced by approximately 33 percent through 
screening and by providing special attention to individuals at 
increased risk for this disease. As a result, in 1997 several major 
health organizations, including the Centers for Disease Control and 
Prevention, recommended routine screening be conducted for colorectal 
cancer among all Americans over 50 years of age in good health. Recent 
documented usage of colorectal cancer screening by the U.S. population, 
however, lags far behind screening for other cancers, such as breast 
and cervical cancers. Finding ways to promote the new recommendation 
for routine colorectal cancer screening among the target population, 
therefore, is a necessity in combating the disease.
    The Division of Cancer Prevention and Control is planning to obtain 
input from the target audience of all adults within the U.S. who are in 
good health and age 50 and older. Information collected from the target 
audience will assist in the design and implementation of a national 
campaign intended to promote screening for colorectal cancer. Such 
information will include knowledge and attitudes regarding colorectal 
screening as well as responses to draft messages promoting screening, 
and will be gathered using focus groups, interviews, and the purchase 
of omnibus survey questions. Information on the estimated annual 
respondent burden is shown in the table below. Based on previous 
formative efforts, the cost to respondents is estimated to be $10 per 
hour, for a total cost of $2,250 for the 225 total burden hours listed.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
                   Respondents                       Number of      responses/     response  (in   Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Focus Groups....................................              50               1            1.5               75
Intercept Interviews............................             100               1            0.5               50

[[Page 11899]]

                                                                                                                
Questions included in omnibus surveys...........            1000               1            0.10             100
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............             225
----------------------------------------------------------------------------------------------------------------

    5. Breast Cancer Incidence in an Occupational Cohort Exposed to 
Ethylene Oxide and in an Occupational Cohort Exposed to Polychlorinated 
Biphenyls (0920-0366)--Extension--Breast cancer is the most common 
incident cancer among U.S. women, and the second leading cause of 
cancer mortality in U.S. women.
    Increasing numbers of women are employed outside the home, yet few 
studies of breast cancer etiology have addressed occupational and 
environmental chemical exposures, and many cancer studies of industrial 
cohorts have excluded women. This study will provide information 
concerning (1) the incidence of breast cancer in a cohort of women 
exposed to ethylene oxide (ETO) and (2) the incidence of breast cancer 
in a cohort of women exposed to polychlorinated biphenyls (PCBs). Both 
compounds are suspected breast carcinogens. These two cohorts have been 
previously assembled by NIOSH, and each represents the largest and best 
defined female study cohort in the U.S. for the respective exposure.
    All women in the existing NIOSH ethylene oxide cohort (n=9,929) and 
PCB cohort (13,736) will be enrolled in the study. For both cohorts, 
data from personnel records has been coded into a computer file 
containing demographic, and work history information. This information 
will be used to estimate workplace exposures. Vital status has been 
determined through automated data sources. Questionnaires are currently 
being mailed to each living cohort member to obtain information on 
breast cancer incidence and risk factors for breast cancer. For 
deceased cohort members, next-of-kin will be asked to provide this 
information. Other record sources such as death certificates and 
population-based cancer incidence registries will also be used to 
identify cancer cases. The diagnosis will be confirmed by medical 
records. Each questionnaire will take approximately 30 minutes to 
complete. The total cost to respondents is $187,500.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
                   Respondents                       Number of      responses/     response  (in   Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Workers.........................................          23,000               1             .50          11,500
Medical providers...............................           2,000               1             .50           1,000
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............          12,500
----------------------------------------------------------------------------------------------------------------

    6. Respiratory Protective Devices--42 CFR 84--Regulation--(0920-
0109)--Extension--The regulatory authority for the National Institute 
for Occupational Safety and Health (.0NIOSH) certification program for 
respiratory protective devices is found in the Mine Safety and Health 
Amendments Act of 1977 (30 U.S.C. 577a, 651 et seq., and 657(g)) and 
the Occupational Safety and Health Act of 1970 (30 U.S.C. 3, 5, 7, 811, 
842(h), 844). These regulations have as their basis the performance 
tests and criteria for approval of respirators used by millions of 
American construction workers, miners, painters, asbestos removal 
workers, fabric mill workers, and fire fighters. In addition to 
benefitting industrial workers, the improved testing requirements also 
benefit health care workers implementing the current CDC Guidelines for 
Preventing the Transmission of Tuberculosis. Regulations of the 
Environmental Protection Agency (EPA) and the Nuclear Regulatory 
Commission (NRC) also require the use of NIOSH-approved respirators.
    NIOSH, in accordance with implementing regulations 42 CFR 84: (1) 
Issues certificates of approval for respirators which have met improved 
construction, performance, and protection requirements; (2) establishes 
procedures and requirements to be met in filing applications for 
approval; (3) specifies minimum requirements and methods to be employed 
by NIOSH and by applicants in conducting inspections, examinations, and 
tests to determine effectiveness of respirators; (4) establishes a 
schedule of fees to be charged applicants for testing and 
certification, and (5) establishes approval labeling requirements. The 
total cost to respondents is $4,691,120.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. Burden/                 
                   Respondents                       Number of      responses/     response  (in   Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Respirator Manufacturers........................              56              14             227         177,968
                                                                                                 ---------------
      Total.....................................  ..............  ..............  ..............         177,968
----------------------------------------------------------------------------------------------------------------


[[Page 11900]]

    Dated: March 5, 1998.
Charles Gollmar,
Acting Associate Director for Policy, Planning, and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 98-6193 Filed 3-10-98; 8:45 am]
BILLING CODE 4163-18-P